Prevalence of sarcopenia in community-dwelling older people of Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria

María Claudia Espinel-Bermúdez, Eliseo Ramírez-García, Carmen García-Peña, Antoni Salvà-Casanovas, Liliana Ruiz-Arregui, Ángel Cárdenas-Bahena, Sergio Sánchez-García


Background: The aim of this study is to determine the prevalence of sarcopenia in community-dwelling older people living in Mexico City using the EGWSOP (European Working Group on Sarcopenia in Older People) diagnostic criteria that include muscle mass, muscle strength and physical performance.

Methods: The sample population was based on older people (≥60 years) affiliated with the Mexican Institute of Social Security in Mexico City. Data were derived from the database of the “Cohort of Obesity, Sarcopenia and Frailty of Older Mexican Adults” (COSFOMA). Sarcopenia was diagnosed using the EGWSOP criteria: gait speed (4 m) <0.8 m/s; handgrip strength (using a dynamometer) <20 kg in females or <30 kg in males, and muscle mass index (MMI) <6.1 kg/m2 in females or <8.5 kg/m2 in males (using bioimpedance analysis).

Results: Thousand hundred seventy-seven subjects were included (median age 68.4 years, 60.2% females). 20.5% had low gait speed (19.1% females and 22.6% males); 62.4% had low handgrip strength (69.9% females and 51.2% males) and 12.3% had low muscle mass (9.9% females and 16.0% males). Only 9.9% of older people with sarcopenia (9.0% females and 11.1% males): 1.9% with severe sarcopenia (1.4% females and 2.6% males) and 8.0% with moderate sarcopenia (7.6% females and 8.5% males).

Conclusions: Sarcopenia is present in one of ten community-dwelling older people residing in Mexico City. According to what has been reported in the literature, the prevalence of sarcopenia in older Mexican adults is similar to the community-dwelling population.

Full Text:



Abellan van Kan G. Epidemiology and consequences of sarcopenia. J Nutr Health Aging. 2009;13:708-12.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.

Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc. 2011;12:249–56.

Cruz-Jentoft AJ, Landi F, Schneider SM, et al. Prevalence of and interventions for sarcopenia in ageing adults: a systematic review. Report of the International Sarcopenia Initiative (EWGSOP and IWGS). Age Ageing. 2014;43:748–59.

Velázquez-Alva MC, Irigoyen Camacho ME, Lazarevich I, et al. Comparison of the prevalence of sarcopenia using skeletal muscle mass index and calf circumference applying the European consensus definition in elderly Mexican women. Geriatr Gerontol Int. 2015; doi:10.1111/ggi.12652.

Lourenço RA, Pérez-Zepeda M, Gutiérrez-Robledo L, García-García FJ, Rodríguez Mañas L. Performance of the European Working Group on Sarcopenia in Older People algorithm in screening older adults for muscle mass assessment. Age Ageing. 2015;44: 334-8.

Arango-Lopera VE, Arroyo P, Gutiérrez-Robledo LM, Pérez-Zepeda MU. Prevalence of sarcopenia in Mexico City. Eur Geriatr Med. 2012;3: 157–60.

Instituto Nacional de Salud Pública. Encuesta Nacional de Salud y Nutrición 2012. Resultados por entidad federativa, Distrito Federal. Cuernavaca, México: Instituto Nacional de Salud Pública; 2013.

Sánchez-García S, García-Peña C, Duque-López MX, Juarez-Cedillo T, Cortés-Núnez AR, Reyes-Beaman S. Anthropometric measures and nutritional status in a healthy elderly population. BMC Public Health. 2007;7:2.

Janssen I, Heymsfield SB, Baumgartner RN, Ross R. Estimation of muscle mass by skeletal bioelectrical impedance analysis. J Appl Physiol. 2000;89:465-71.

Cuesta F, Formiga F, Lopez-Soto A, et al. Prevalence of sarcopenia in patients attending outpatient geriatric clinics: the ELLI study. Age Ageing. 2015;44:807-9.

Beaudart C, Rizzoli R, Bruyère O, Reginster JY, Biver E. Sarcopenia: burden and challenges for public health. Arch Public Health. 2014;72:45.

Bahat G, Tufan A, Tufan F, et al. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition. Clin Nutr. 2016;pii: S0261-5614(16)00058-3.

Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol. 1998;147:755-63.

Masanes F, Culla A, Navarro-Gonzalez M, et al. Prevalence of sarcopenia in healthy community-dwelling elderly in an urban area of Barcelona (Spain). J Nutr Health Aging. 2012;16:184-7.

Cruz-Jentoft AJ, Michel J-P. Sarcopenia: a useful paradigm for physical frailty. Eur Geriatr Med. 2013;4:102–5.

Morley JE, Haehling S, Anker SD, Vellas B. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle. 2014;5:5–8.

Reijnierse EM, Trappenburg MC, Blauw GJ, et al. Common ground? The concordance of sarcopenia and frailty definitions. J Am Med Dir Assoc. 2016;17:371.e7-371.e12.

Tay L, Ding Y, Leung BP, et al. Sex-specific differences in risk factors for sarcopenia amongst community-dwelling older adults. Age. 2015;37:121.

Gallagher D, Visser M, De Meersman RE, et al. Appendicular skeletal muscle mass: effects of age, gender, and ethnicity. J Appl Physiol. 1997;83:229-39.

Frontera WR, Suh D, Krivickas LS, Hughes VA, Goldstein R, Roubenoff R. Skeletal muscle fiber quality in older men and women. Am J Physiol Cell Physiol. 2000;279:C611-18.

Hughes VA, Frontera WR, Wood M, et al. Longitudinal muscle strength changes in older adults: influence of muscle mass, physical activity, and health. J Gerontol A Biol Sci Med Sci. 2001;56A:209-17.

Janssen I, Shepard DS, Katzmarzyk PT, Roubenoff R. The healthcare costs of sarcopenia in the United States. J Am Geriatr Soc. 2004;52:80-5.

von Haehling S, Morley JE, Coats AJS, Anker SD. Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2015. J Cachexia Sarcopenia Muscle 2015;6: 315-16.



  • There are currently no refbacks.